Stericycle Inc (SRCL) : Levasseur Capital Partners has sold out all of its stake in Stericycle Inc during the most recent quarter, according to the disclosure filed by the company on Nov 14, 2016 with the SEC. The investment management company has sold out 96,707 shares of Stericycle Inc which is valued at $7,241,420.
Other Hedge Funds, Including , Clearbridge added SRCL to its portfolio by purchasing 899,330 company shares during the most recent quarter which is valued at $67,341,830. Stericycle Inc makes up approx 1.26% of Clearbridge’s portfolio. Stephens Investment Management Group sold out all of its stake in SRCL during the most recent quarter. The investment firm sold 123,645 shares of SRCL which is valued $9,238,754. Cibc World Markets sold out all of its stake in SRCL during the most recent quarter. The investment firm sold 7,250 shares of SRCL which is valued $529,613.Mycio Wealth Partners boosted its stake in SRCL in the latest quarter, The investment management firm added 700 additional shares and now holds a total of 2,400 shares of Stericycle Inc which is valued at $175,320. Stericycle Inc makes up approx 0.03% of Mycio Wealth Partners’s portfolio. Weatherly Asset Management L. P. sold out all of its stake in SRCL during the most recent quarter. The investment firm sold 2,145 shares of SRCL which is valued $163,084.
Stericycle Inc opened for trading at $75.21 and hit $76.42 on the upside on Monday, eventually ending the session at $76.09, with a gain of 1.09% or 0.82 points. The heightened volatility saw the trading volume jump to 10,27,188 shares. Company has a market cap of $6,474 M.
On the company’s financial health, Stericycle Inc reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Oct 27, 2016. Analyst had a consensus of $1.17. The company had revenue of $890.10 million for the quarter, compared to analysts expectations of $899.87 million. The company’s revenue was up 23.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.08 EPS.
Many Wall Street Analysts have commented on Stericycle Inc. Stericycle Inc was Downgraded by Goldman to ” Sell” on Nov 3, 2016. Stifel Upgraded Stericycle Inc on Oct 28, 2016 to ” Buy”, Price Target of the shares are set at $90.Shares were Reiterated by Barrington Research on Oct 5, 2016 to “Outperform” and Lowered the Price Target to $ 88 from a previous price target of $100 .
Stericycle Inc. is engaged in the business of providing regulated and compliance solutions to healthcare and commercial businesses. The Companys solutions include the collection and processing of specialized waste for disposal and a variety of training consulting recall/return communication and compliance services which include training consulting inbound/outbound communications data reporting and other regulatory compliance services. The Company operates regulated waste management networks in the United States Argentina Brazil Canada Chile Ireland Japan Mexico Portugal Romania South Korea Spain and the United Kingdom. The Company operates through two segments: United States and International. The Companys networks include a total of 181 processing facilities 214 transfer sites and 97 other service facilities. Its regulated waste processing technology is primarily autoclaving. The Company also uses incineration and electro-thermal-deactivation system (ETD).